1. Home
  2. Stock quotes
  3. Stock Aileron Therapeutics
Aileron Therapeutics logo

Aileron Therapeutics ALRN

Annual report 2025
added 03-26-2026

report update icon

Country

 usaUSA

IPO year

 2017

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 25.4 M

Market Cap[1]

 $ 9.8 M

EBITDA (LTM)

 $ -26.4 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -1.01

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Aligos Therapeutics Aligos Therapeutics
ALGS
 		$ 8.64 8.07 % $ 85.4 M Nasdaq Global Select Market usaUSA
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
 		- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		$ 3.66 -1.48 % $ 8.81 B Nasdaq Capital Market australiaAustralia
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
 		$ 3.11 5.42 % $ 265 M Nasdaq Capital Market usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Cabaletta Bio Cabaletta Bio
CABA
 		$ 3.2 2.24 % $ 322 M Nasdaq Global Select Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		$ 21.36 4.86 % $ 998 M Nasdaq Global Select Market usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		- - $ 169 M Nasdaq Capital Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		- - $ 86.2 M Nasdaq Global Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
 		- - $ 25.3 M Nasdaq Global Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		$ 1.47 5.0 % $ 378 M Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		$ 2.92 - $ 4.81 M NYSE American israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		$ 4.19 2.7 % $ 448 M Nasdaq Global Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		$ 24.12 -0.37 % $ 3.07 B Nasdaq Global Select Market,SPB usaUSA
Chimerix Chimerix
CMRX
 		- - $ 756 M Nasdaq Global Select Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		- - $ 401 M Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		$ 32.59 1.09 % $ 2.16 B Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		$ 1.47 -1.34 % $ 391 M Nasdaq Global Select Market britainBritain
Aptose Biosciences Aptose Biosciences
APTO
 		- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Cidara Therapeutics Cidara Therapeutics
CDTX
 		- - $ 1.41 B Nasdaq Global Market usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
 		$ 2.44 11.7 % $ 1.08 M Nasdaq Capital Market usaUSA
AVROBIO AVROBIO
AVRO
 		- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
 		- - $ 96.9 B Nasdaq Global Select Market britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		- - $ 1.2 B Nasdaq Capital Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
 		$ 4.25 8.35 % $ 286 B Nasdaq Capital Market britainBritain
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.